SonoThera
Developing ultrasound-mediated nonviral genetic medicines.
About
SonoThera is a biotechnology company developing a proprietary, non-invasive approach to genetic medicine using ultrasound-mediated delivery (UMD). This technology enables broad, highly targeted biodistribution of diverse genetic payloads, including DNA and RNA constructs of unlimited size, in a redosable and cost-effective manner. SonoThera aims to bring this safe and well-tolerated genetic medicine to patients. Teams look it up for Biotechnology, Healthcare, Gene Therapy.
Frequently asked
What does SonoThera do?
SonoThera is a Biotechnology company that offers Services. Teams look it up for Healthcare, Gene Therapy, Medical Devices. It is based in San Francisco, California, USA and was founded in 2019. Public records show about 54 people and $125M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has SonoThera raised?
SonoThera has raised a total of $125M in funding. The most recent round on record is Series B.
Where is SonoThera headquartered?
SonoThera is headquartered in San Francisco, California, USA.
When was SonoThera founded?
SonoThera was founded in 2019.
What industry does SonoThera operate in?
SonoThera operates in Biotechnology, Healthcare, Gene Therapy, Medical Devices, Biotech.
How many employees does SonoThera have?
SonoThera has approximately 54 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.